108 related articles for article (PubMed ID: 3096353)
1. HDL-cholesterol sparing and APO-B removal in recycled cascade plasmafiltration.
Busnach G; Brando B; Dal Col A; Perrino ML; Zoppi F; Minetti L
ASAIO Trans; 1986; 32(1):168-70. PubMed ID: 3096353
[No Abstract] [Full Text] [Related]
2. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
Lai KN; Cheng SC; Vallance-Owen J
Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
Kaplan AA
Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
[TBL] [Abstract][Full Text] [Related]
4. Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies.
Levy Y; Aviram M; Spira G; Tatarsky I; Brook GJ; Carter A
Postgrad Med J; 1984 Jul; 60(705):449-53. PubMed ID: 6431399
[TBL] [Abstract][Full Text] [Related]
5. [Effects of a thymus extract on blood levels of apo A and apo B in rats on a hypercholesterolemic diet].
Mondola P; Santangelo F; Falconi C; Belfiore A; Santillo M
Boll Soc Ital Biol Sper; 1986 Dec; 62(12):1457-64. PubMed ID: 3580179
[No Abstract] [Full Text] [Related]
6. [Selective depuration of plasma by filtration. An alternative to plasma exchange].
Puig LL; Mazzara R; Montesinos A; Gelabert A; Castillo R
Sangre (Barc); 1988 Apr; 33(2):114-20. PubMed ID: 3135612
[No Abstract] [Full Text] [Related]
7. [Association of glomerulonephritis in essential mixed cryoglobulinemia with IgA nephropathy. Effect of treatment with plasmapheresis and chlorbutin].
Andreeva NE; Nikolaev AIu; Varshavskii VA; Chernokhvostova EV; Guseĭnova LA
Ter Arkh; 1984; 56(7):97-9. PubMed ID: 6237456
[No Abstract] [Full Text] [Related]
8. [Importance of apolipoproteins A-1 and B in acute viral hepatitis and hepatic cirrhosis].
Jorge AD; Ponce G; Milutín C; Sánchez D; Díaz M; Pérez R; Esley C
Acta Gastroenterol Latinoam; 1986; 16(1):39-46. PubMed ID: 3577619
[TBL] [Abstract][Full Text] [Related]
9. [Plasma levels of apolipoprotein and HDL-cholesterol in patients with rheumatoid arthritis].
Frati E; Castagna ML; Bacarelli MR; Fioravanti A; Giordano N; Taddeo A; Marcolongo R
Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1791-6. PubMed ID: 6525299
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic apheresis: when things go wrong.
Torloni AS; Lumadue J; Zubair A
J Clin Apher; 2012; 27(3):168-71. PubMed ID: 22504899
[TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera.
Waldenström JG; Raiend U
Acta Med Scand; 1984; 216(5):449-66. PubMed ID: 6441457
[TBL] [Abstract][Full Text] [Related]
12. [Serum lipids and apolipoproteins AI, B100, CI and CII in patients with apoplexy].
Liu BW; Zhang ZH; Wu ZF; Fu MD; Zhang RJ; Fan P; Zhang P; Hu CH; Luo ZM; She LM
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Mar; 20(1):9-12. PubMed ID: 2507441
[TBL] [Abstract][Full Text] [Related]
13. The effect of acebutolol on plasma apoproteins and HDL cholesterol subfractions.
Lehtonen A; Marniemi J; Niittymäki K
Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):427-35. PubMed ID: 3922021
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based focused review of management of hyperviscosity syndrome.
Stone MJ; Bogen SA
Blood; 2012 Mar; 119(10):2205-8. PubMed ID: 22147890
[No Abstract] [Full Text] [Related]
15. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients.
Burrell D; Antignani A; Fein PA; Goldwasser P; Mittman N; Avram MM
ASAIO Trans; 1990; 36(3):M331-5. PubMed ID: 2123635
[TBL] [Abstract][Full Text] [Related]
16. [Plasma level of total cholesterol, triglycerides, HDL-C, and apolipoproteins A-I and B in normal and healthy Chinese adults].
Mu JY; Cheung MH; Lin HF
Zhonghua Yi Xue Za Zhi (Taipei); 1988 Apr; 41(4):255-62. PubMed ID: 3179813
[No Abstract] [Full Text] [Related]
17. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
Luoma PV; Marniemi J; Sotaniemi EA
Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of apolipoproteins is better than routinely measured traditional lipids].
Kallner A; Estonius M
Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202
[No Abstract] [Full Text] [Related]
19. Association between serum concentration of apolipoproteins A-I and B with gallbladder disease.
Morán S; Duque-López MX; Salmerón-Castro J; Rodríguez-Leal G; Martínez-Salgado H; Uribe M
Arch Med Res; 2003; 34(3):194-9. PubMed ID: 14567398
[TBL] [Abstract][Full Text] [Related]
20. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
